The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Infertility Testing and Treatment Market Research Report 2025
Synopsis
Fertility testing is done by both men and women for the evaluation of their fertility and various conditions associated with it. The assessment of infertility proceeds along simple and logical lines which includes test for eggs, test for sperm, and how they can get together. Additional tests are performed based on the completion of this three step process. Men and women both experience the fertility problems at equal rates, but women are considered to be more concerned regarding fertility testing.
The global Infertility Testing and Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Infertility Testing and Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infertility Testing and Treatment.
Report Scope
The Infertility Testing and Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Infertility Testing and Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Infertility Testing and Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Procter & Gamble
BioMerieux
Abbott
Babystart
BioZhena Corporation
Quidel Corporation
SPD Swiss Precision Diagnostics
SCSA Diagnostics
Pride Angel
Segment by Type
Female Infertility Testing
Male Infertility Testing
Segment by Application
Hospitals
Clinics
Fertility Centers
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Infertility Testing and Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Fertility testing is done by both men and women for the evaluation of their fertility and various conditions associated with it. The assessment of infertility proceeds along simple and logical lines which includes test for eggs, test for sperm, and how they can get together. Additional tests are performed based on the completion of this three step process. Men and women both experience the fertility problems at equal rates, but women are considered to be more concerned regarding fertility testing.
The global Infertility Testing and Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Infertility Testing and Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infertility Testing and Treatment.
Report Scope
The Infertility Testing and Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Infertility Testing and Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Infertility Testing and Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Procter & Gamble
BioMerieux
Abbott
Babystart
BioZhena Corporation
Quidel Corporation
SPD Swiss Precision Diagnostics
SCSA Diagnostics
Pride Angel
Segment by Type
Female Infertility Testing
Male Infertility Testing
Segment by Application
Hospitals
Clinics
Fertility Centers
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Infertility Testing and Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infertility Testing and Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Female Infertility Testing
1.2.3 Male Infertility Testing
1.3 Market by Application
1.3.1 Global Infertility Testing and Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Fertility Centers
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Infertility Testing and Treatment Market Perspective (2019-2030)
2.2 Infertility Testing and Treatment Growth Trends by Region
2.2.1 Global Infertility Testing and Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Infertility Testing and Treatment Historic Market Size by Region (2019-2024)
2.2.3 Infertility Testing and Treatment Forecasted Market Size by Region (2025-2030)
2.3 Infertility Testing and Treatment Market Dynamics
2.3.1 Infertility Testing and Treatment Industry Trends
2.3.2 Infertility Testing and Treatment Market Drivers
2.3.3 Infertility Testing and Treatment Market Challenges
2.3.4 Infertility Testing and Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Infertility Testing and Treatment Players by Revenue
3.1.1 Global Top Infertility Testing and Treatment Players by Revenue (2019-2024)
3.1.2 Global Infertility Testing and Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Infertility Testing and Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Infertility Testing and Treatment Revenue
3.4 Global Infertility Testing and Treatment Market Concentration Ratio
3.4.1 Global Infertility Testing and Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infertility Testing and Treatment Revenue in 2023
3.5 Infertility Testing and Treatment Key Players Head office and Area Served
3.6 Key Players Infertility Testing and Treatment Product Solution and Service
3.7 Date of Enter into Infertility Testing and Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Infertility Testing and Treatment Breakdown Data by Type
4.1 Global Infertility Testing and Treatment Historic Market Size by Type (2019-2024)
4.2 Global Infertility Testing and Treatment Forecasted Market Size by Type (2025-2030)
5 Infertility Testing and Treatment Breakdown Data by Application
5.1 Global Infertility Testing and Treatment Historic Market Size by Application (2019-2024)
5.2 Global Infertility Testing and Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Infertility Testing and Treatment Market Size (2019-2030)
6.2 North America Infertility Testing and Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Infertility Testing and Treatment Market Size by Country (2019-2024)
6.4 North America Infertility Testing and Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Infertility Testing and Treatment Market Size (2019-2030)
7.2 Europe Infertility Testing and Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Infertility Testing and Treatment Market Size by Country (2019-2024)
7.4 Europe Infertility Testing and Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Infertility Testing and Treatment Market Size (2019-2030)
8.2 Asia-Pacific Infertility Testing and Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Infertility Testing and Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Infertility Testing and Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Infertility Testing and Treatment Market Size (2019-2030)
9.2 Latin America Infertility Testing and Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Infertility Testing and Treatment Market Size by Country (2019-2024)
9.4 Latin America Infertility Testing and Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Infertility Testing and Treatment Market Size (2019-2030)
10.2 Middle East & Africa Infertility Testing and Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Infertility Testing and Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Infertility Testing and Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Detail
11.1.2 Merck Business Overview
11.1.3 Merck Infertility Testing and Treatment Introduction
11.1.4 Merck Revenue in Infertility Testing and Treatment Business (2019-2024)
11.1.5 Merck Recent Development
11.2 Procter & Gamble
11.2.1 Procter & Gamble Company Detail
11.2.2 Procter & Gamble Business Overview
11.2.3 Procter & Gamble Infertility Testing and Treatment Introduction
11.2.4 Procter & Gamble Revenue in Infertility Testing and Treatment Business (2019-2024)
11.2.5 Procter & Gamble Recent Development
11.3 BioMerieux
11.3.1 BioMerieux Company Detail
11.3.2 BioMerieux Business Overview
11.3.3 BioMerieux Infertility Testing and Treatment Introduction
11.3.4 BioMerieux Revenue in Infertility Testing and Treatment Business (2019-2024)
11.3.5 BioMerieux Recent Development
11.4 Abbott
11.4.1 Abbott Company Detail
11.4.2 Abbott Business Overview
11.4.3 Abbott Infertility Testing and Treatment Introduction
11.4.4 Abbott Revenue in Infertility Testing and Treatment Business (2019-2024)
11.4.5 Abbott Recent Development
11.5 Babystart
11.5.1 Babystart Company Detail
11.5.2 Babystart Business Overview
11.5.3 Babystart Infertility Testing and Treatment Introduction
11.5.4 Babystart Revenue in Infertility Testing and Treatment Business (2019-2024)
11.5.5 Babystart Recent Development
11.6 BioZhena Corporation
11.6.1 BioZhena Corporation Company Detail
11.6.2 BioZhena Corporation Business Overview
11.6.3 BioZhena Corporation Infertility Testing and Treatment Introduction
11.6.4 BioZhena Corporation Revenue in Infertility Testing and Treatment Business (2019-2024)
11.6.5 BioZhena Corporation Recent Development
11.7 Quidel Corporation
11.7.1 Quidel Corporation Company Detail
11.7.2 Quidel Corporation Business Overview
11.7.3 Quidel Corporation Infertility Testing and Treatment Introduction
11.7.4 Quidel Corporation Revenue in Infertility Testing and Treatment Business (2019-2024)
11.7.5 Quidel Corporation Recent Development
11.8 SPD Swiss Precision Diagnostics
11.8.1 SPD Swiss Precision Diagnostics Company Detail
11.8.2 SPD Swiss Precision Diagnostics Business Overview
11.8.3 SPD Swiss Precision Diagnostics Infertility Testing and Treatment Introduction
11.8.4 SPD Swiss Precision Diagnostics Revenue in Infertility Testing and Treatment Business (2019-2024)
11.8.5 SPD Swiss Precision Diagnostics Recent Development
11.9 SCSA Diagnostics
11.9.1 SCSA Diagnostics Company Detail
11.9.2 SCSA Diagnostics Business Overview
11.9.3 SCSA Diagnostics Infertility Testing and Treatment Introduction
11.9.4 SCSA Diagnostics Revenue in Infertility Testing and Treatment Business (2019-2024)
11.9.5 SCSA Diagnostics Recent Development
11.10 Pride Angel
11.10.1 Pride Angel Company Detail
11.10.2 Pride Angel Business Overview
11.10.3 Pride Angel Infertility Testing and Treatment Introduction
11.10.4 Pride Angel Revenue in Infertility Testing and Treatment Business (2019-2024)
11.10.5 Pride Angel Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
